McKesson Total Non-Operating Income/Expense 2010-2024 | MCK
McKesson annual/quarterly total non-operating income/expense history and growth rate from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
- McKesson total non-operating income/expense for the quarter ending September 30, 2024 was $-0.044B, a 25.71% increase year-over-year.
- McKesson total non-operating income/expense for the twelve months ending September 30, 2024 was $-65M, a 156.52% decline year-over-year.
- McKesson annual total non-operating income/expense for 2024 was $-0.12B, a 148.19% decline from 2023.
- McKesson annual total non-operating income/expense for 2023 was $0.249B, a 326.36% decline from 2022.
- McKesson annual total non-operating income/expense for 2022 was $-0.11B, a 1933.33% decline from 2021.
McKesson Annual Total Non-Operating Income/Expense
(Millions of US $) |
| 2024 |
$-120 |
| 2023 |
$249 |
| 2022 |
$-110 |
| 2021 |
$6 |
| 2020 |
$-1,345 |
| 2019 |
$-276 |
| 2018 |
$-523 |
| 2017 |
$-231 |
| 2016 |
$-295 |
| 2015 |
$-311 |
| 2014 |
$-268 |
| 2013 |
$-397 |
| 2012 |
$-231 |
| 2011 |
$-186 |
| 2010 |
$-144 |
| 2009 |
$-132 |
McKesson Quarterly Total Non-Operating Income/Expense
(Millions of US $) |
| 2024-09-30 |
$-44 |
| 2024-06-30 |
$55 |
| 2024-03-31 |
$-46 |
| 2023-12-31 |
$-30 |
| 2023-09-30 |
$-35 |
| 2023-06-30 |
$-9 |
| 2023-03-31 |
$-48 |
| 2022-12-31 |
$207 |
| 2022-09-30 |
$120 |
| 2022-06-30 |
$-30 |
| 2022-03-31 |
$14 |
| 2021-12-31 |
$-21 |
| 2021-09-30 |
$-97 |
| 2021-06-30 |
$-6 |
| 2021-03-31 |
$19 |
| 2020-12-31 |
$-1 |
| 2020-09-30 |
$21 |
| 2020-06-30 |
$-33 |
| 2020-03-31 |
$332 |
| 2019-12-31 |
$-66 |
| 2019-09-30 |
$-1,596 |
| 2019-06-30 |
$-15 |
| 2019-03-31 |
$-64 |
| 2018-12-31 |
$-33 |
| 2018-09-30 |
$-102 |
| 2018-06-30 |
$-77 |
| 2018-03-31 |
$-150 |
| 2017-12-31 |
$-137 |
| 2017-09-30 |
$-61 |
| 2017-06-30 |
$-175 |
| 2017-03-31 |
$-65 |
| 2016-12-31 |
$-51 |
| 2016-09-30 |
$-55 |
| 2016-06-30 |
$-60 |
| 2016-03-31 |
$-71 |
| 2015-12-31 |
$-74 |
| 2015-09-30 |
$-74 |
| 2015-06-30 |
$-76 |
| 2015-03-31 |
$-80 |
| 2014-12-31 |
$-81 |
| 2014-09-30 |
$-73 |
| 2014-06-30 |
$-77 |
| 2014-03-31 |
$-90 |
| 2013-12-31 |
$-75 |
| 2013-09-30 |
$-50 |
| 2013-06-30 |
$-53 |
| 2013-03-31 |
$-255 |
| 2012-12-31 |
$-49 |
| 2012-09-30 |
$-45 |
| 2012-06-30 |
$-48 |
| 2012-03-31 |
$-51 |
| 2011-12-31 |
$-66 |
| 2011-09-30 |
$-58 |
| 2011-06-30 |
$-56 |
| 2011-03-31 |
$-65 |
| 2010-12-31 |
$-46 |
| 2010-09-30 |
$-41 |
| 2010-06-30 |
$-34 |
| 2010-03-31 |
$-41 |
| 2009-12-31 |
$-22 |
| 2009-09-30 |
$-43 |
| 2009-06-30 |
$-38 |
| 2009-03-31 |
$-101 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$79.492B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
